Agnovos Healthcare LLC, a company using regenerative medicine to treat localized effects of bone disease, has received the FDA’s nod for an IDE clinical trial to assess its AGN1 local ...
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results